Company news

Marker Therapeutics, Inc. news in 2019

Marker Therapeutics, Inc.'s news releases, calls and decks from 2019, newest first.

View company

Marker Therapeutics Reports Third Quarter 2019 Operating and Financial Results

November 11, 2019

Marker Therapeutics to Host Third Quarter 2019 Operating and Financial Results Conference Call and Webcast on Tuesday, November 12, 2019

November 10, 2019

Marker Therapeutics Appoints Nadia Agopyan, Ph.D., RAC as Vice President of Regulatory Affairs

August 14, 2019

Marker Therapeutics Reports Second Quarter 2019 Operating and Financial Results

August 7, 2019

Marker Therapeutics Reports Interim Results of its MultiTAA T Cell Therapy in Patients with Pancreatic Adenocarcinoma at AACR

July 19, 2019

Marker Therapeutics to Host Conference Call and Webcast to Review Interim Results from Phase 1/2 Clinical Trial with its MultiTAA T Cell Therapy in Patients with Pancreatic Adenocarcinoma

July 16, 2019

Marker Therapeutics to Report Updated Results from Phase 1/2 Trial with MultiTAA Therapy in Patients with Pancreatic Adenocarcinoma

June 19, 2019

Decks in 2019